| scholarly article | Q13442814 |
| P50 | author | Stephan von Hörsten | Q37368871 |
| Huu Phuc Nguyen | Q62755583 | ||
| Valérie Doyère | Q72728265 | ||
| Olaf Riess | Q83912532 | ||
| Nicole El Massioui | Q114425266 | ||
| Alexis Faure | Q114425288 | ||
| Nathalie Desvignes | Q114425289 | ||
| P2093 | author name string | Bruce L Brown | |
| Yvonne K Urbach | |||
| Glenn Dallérac | |||
| Pascale Le Blanc | |||
| Sophie Höhn | |||
| P2860 | cites work | Neuroanatomical and neurochemical substrates of timing | Q24602685 |
| Short-term synaptic plasticity | Q28217342 | ||
| Differential effects of cocaine and ketamine on time estimation: implications for neurobiological models of interval timing | Q28258895 | ||
| What makes us tick? Functional and neural mechanisms of interval timing | Q28272313 | ||
| Use of a modified prepulse inhibition paradigm to assess complex auditory discrimination in rodents | Q30444514 | ||
| Self-paced timing detects and tracks change in prodromal Huntington disease | Q30474980 | ||
| Mutant huntingtin enhances excitotoxic cell death. | Q31847067 | ||
| Time processing in Huntington's disease: a group-control study | Q33308722 | ||
| Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease | Q33923206 | ||
| Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice | Q34098463 | ||
| The discrimination of stimulus duration by pigeons | Q34281046 | ||
| Behavioral phenotyping of mice in pharmacological and toxicological research | Q35206576 | ||
| Learning insights transmitted by glutamate. | Q35872322 | ||
| In vivo activity-dependent plasticity at cortico-striatal connections: evidence for physiological long-term potentiation | Q36247620 | ||
| Is Huntington's a glutamine storage disease? | Q36535666 | ||
| The corticostriatal pathway in Huntington's disease | Q36684263 | ||
| Detection of Huntington's disease decades before diagnosis: the Predict-HD study | Q36941187 | ||
| Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease | Q36956907 | ||
| Altered information processing in the prefrontal cortex of Huntington's disease mouse models | Q37002862 | ||
| Dysregulation of coordinated neuronal firing patterns in striatum of freely behaving transgenic rats that model Huntington's disease | Q37456285 | ||
| Neuropharmacological evidence for different timing mechanisms in humans | Q38448399 | ||
| Evidence for specific cognitive deficits in preclinical Huntington's disease. | Q38452724 | ||
| Memory failure in Huntington's disease | Q38489470 | ||
| fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease. | Q42471124 | ||
| Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers | Q42669515 | ||
| Impaired long-term potentiation in the prefrontal cortex of Huntington's disease mouse models: rescue by D1 dopamine receptor activation | Q42688388 | ||
| Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease | Q43925468 | ||
| Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. | Q44306949 | ||
| Transgenic rat model of Huntington's disease | Q44350467 | ||
| Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease | Q44806645 | ||
| Cognitive scores in carriers of Huntington's disease gene compared to noncarriers | Q45288503 | ||
| Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters | Q45292416 | ||
| Executive and mnemonic functions in early Huntington's disease | Q45293389 | ||
| Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases | Q45293874 | ||
| Huntington's disease and eyeblink classical conditioning: normal learning but abnormal timing | Q45295305 | ||
| Disrupted temporal control in the R6/2 mouse model of Huntington's disease | Q45296092 | ||
| Neuropathological classification of Huntington's disease | Q45297167 | ||
| Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats | Q45300103 | ||
| Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease. | Q45300648 | ||
| Altered emotional and motivational processing in the transgenic rat model for Huntington's disease. | Q45300705 | ||
| Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease. | Q45302139 | ||
| Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. | Q45302545 | ||
| Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches | Q45304893 | ||
| Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6/2 mouse model of Huntington's disease | Q45305026 | ||
| Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load | Q45306738 | ||
| Cortical and brainstem LTP-like plasticity in Huntington's disease | Q45307344 | ||
| Impairments in timing, temporal memory, and reversal learning linked to neurotoxic regimens of methamphetamine intoxication | Q46904503 | ||
| In vivo induction of striatal long-term potentiation by low-frequency stimulation of the cerebral cortex | Q48172736 | ||
| Neurobehavioral tests in rat models of degenerative brain diseases | Q48377898 | ||
| Neuroanatomical localization of an internal clock: a functional link between mesolimbic, nigrostriatal, and mesocortical dopaminergic systems | Q48454454 | ||
| The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems | Q48614166 | ||
| Cognitive processing impairments in a supra-second temporal discrimination task in rats with cerebellar lesion. | Q51944184 | ||
| Single-trials analyses demonstrate that increases in clock speed contribute to the methamphetamine-induced horizontal shifts in peak-interval timing functions. | Q52008845 | ||
| Selective adjustment of the speed of internal clock and memory processes. | Q52095788 | ||
| The location and interpretation of the bisection point. | Q52122545 | ||
| The differential effects of haloperidol and methamphetamine on time estimation in the rat. | Q52284630 | ||
| Bisection of temporal intervals. | Q52306771 | ||
| Categorical Scaling of Duration Bisection in Pigeons (Columba livia), Mice (Mus musculus), and Humans (Homo sapiens) | Q60147270 | ||
| Changes in the statistics of transmitter release during facilitation | Q68658010 | ||
| Methamphetamine and time estimation | Q70766468 | ||
| Discriminating time intervals presented in sequences marked by visual signals | Q77420949 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Huntington's disease | Q190564 |
| electrophysiology | Q1154774 | ||
| P304 | page(s) | 8986-8997 | |
| P577 | publication date | 2011-06-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Behavioral and in vivo electrophysiological evidence for presymptomatic alteration of prefrontostriatal processing in the transgenic rat model for huntington disease | |
| P478 | volume | 31 |
| Q34281322 | Aberrant calcium signaling by transglutaminase-mediated posttranslational modification of inositol 1,4,5-trisphosphate receptors |
| Q35828268 | Acquisition of "Start" and "Stop" response thresholds in peak-interval timing is differentially sensitive to protein synthesis inhibition in the dorsal and ventral striatum |
| Q48018689 | Acquisition of response thresholds for timed performance is regulated by a calcium-responsive transcription factor, CaRF. |
| Q36652239 | Altered diffusion tensor imaging measurements in aged transgenic Huntington disease rats |
| Q42190041 | Changes in striatal activity and functional connectivity in a mouse model of Huntington's disease |
| Q33928892 | Contralateral disconnection of the rat prelimbic cortex and dorsomedial striatum impairs cue-guided behavioral switching |
| Q26738379 | Corticostriatal Dysfunction in Huntington's Disease: The Basics |
| Q38035863 | Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes |
| Q38810866 | Dopamine Modulates Striato-Frontal Functioning during Temporal Processing |
| Q49560971 | Early Alterations in Operant Performance and Prominent Huntingtin Aggregation in a Congenic F344 Rat Line of the Classical CAGn51trunc Model of Huntington Disease |
| Q42115240 | Exploring the 4th dimension: hippocampus, time, and memory revisited |
| Q37366142 | Impaired Decision Making and Loss of Inhibitory-Control in a Rat Model of Huntington Disease |
| Q33646870 | Infant rats can learn time intervals before the maturation of the striatum: evidence from odor fear conditioning |
| Q48337092 | Interactions between medial prefrontal cortex and dorsomedial striatum are necessary for odor span capacity in rats: role of GluN2B-containing NMDA receptors |
| Q27027178 | Lessons learned from the transgenic Huntington's disease rats |
| Q37199264 | Modified impact of emotion on temporal discrimination in a transgenic rat model of Huntington disease |
| Q36378946 | Pathophysiological distortions in time perception and timed performance. |
| Q37727479 | Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington's Disease: Are They Fit-for-Purpose for Treatment Development? |
| Q35342635 | Rapid and acute effects of estrogen on time perception in male and female rats |
| Q26829211 | Role of cerebral cortex in the neuropathology of Huntington's disease |
| Q98386122 | Short and long-term evaluation of the impact of proton minibeam radiation therapy on motor, emotional and cognitive functions |
| Q35547615 | Temporal sensitivity changes with extended training in a bisection task in a transgenic rat model |
| Q55121407 | The Alteration of Emotion Regulation Precedes the Deficits in Interval Timing in the BACHD Rat Model for Huntington Disease. |
| Q64080126 | The Disruption of Memory Consolidation of Duration Introduces Noise While Lengthening the Long-Term Memory Representation of Time in Humans |
| Q90593606 | The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease |
| Q36584694 | The amygdalo-nigrostriatal network is critical for an optimal temporal performance |
| Q42435280 | The dopaminergic stabilizer pridopidine increases neuronal activity of pyramidal neurons in the prefrontal cortex |
| Q30834706 | Updating temporal expectancy of an aversive event engages striatal plasticity under amygdala control |
Search more.